That Ensure Benefits of Personalized Treatment HUNTINGTON BEACH, Calif., and AMSTERDAM, Netherlands, Sept. 4
/PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics,
today announced the launch of TargetPrint(R), a new diagnostic test that
allows physicians to quantitatively determine the gene expression levels of
the estrogen receptor (ER), progesterone receptor (PR) and Human Epidermal
growth factor Receptor 2 (HER2) in breast cancer tumor biopsies. The
accurate measurement of these receptors is of paramount importance in
planning treatment of breast cancer patients after surgery and assists
physicians and patients in making informed treatment decisions. TargetPrint
runs on Agendia's new High Density Chip, which received market clearance
last month (August 2008) from the U.S. Food and Drug Administration (FDA).

"Currently available targeted therapies, such as hormone treatments,
can have a huge impact on the survival and quality of life of a significant
number of breast cancer patients," said Bernhard Sixt, Ph.D., president and
chief executive officer of Agendia. "TargetPrint will play a key role in
defining which patients are most likely to benefit from these treatments."

"The test's results give a precise molecular read-out of prognostic
parameters for breast cancer and provide physicians and patients with
reliable guidance on the most suitable treatment for each individual
patient," said Richard A. Bender, MD, FACP, chief medical officer of
Agendia. "In the near future, it is our plan to add information on a wider
range of drug targets to TargetPrint and clinically validate these with key
customers."

Agendia will present clinical data on TargetPrint at The 2008 Breast
Cancer Symposium which is co-sponsored by the American Society of Clinical
Oncology (ASCO) and will be held in Washington, DC from September 5-7,
2008. TargetPrint is processed at Agendia's Clinical Laboratory Improvement
Amendments (CLIA) certified and the College of American Pathology (CAP)
accredited laboratory.

About Agendia

Agendia is a world leader in molecular cancer diagnostics. The company
markets four products based on its breakthrough platform for tumor gene
expression profiling and has several new diagnostic tests under
development. Agendia was the first company to receive FDA clearance for a
breast cancer test, MammaPrint(R), that predicts the risk of breast cancer
recurrence. In addition, the company collaborates with pharma companies to
develop highly effective personalized drugs in the area of oncology.
Agendia is based in Huntington Beach, California, and in Amsterdam, The
Netherlands. For more information on Agendia, please visit http://www.agendia.com.

(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...

(Date:10/13/2017)... ... , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many ... event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids ... of all ages; it is a non-competitive, non-timed event, which is all about having ...

(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...

(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...

(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...

(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and fastest ... to open a flagship location in Covington, LA at 401 N. U.S. Highway 190, ... next to Office Depot in the Holiday Square shopping center. Its location allows it ...